Statements 25 Sep 2026 DNDi intervention at the UN High-Level Meeting on Pandemic Prevention, Preparedness, and Response at the 81st UN General Assembly
In the media 24 Sep 2026 De Etiopía a Lleida: la desigualdad mata tanto como los virus durante una pandemia El País
News 15 Sep 2026 New DNDi report: Implementing Article 9.5 of the WHO Pandemic Agreement – building on current policy and practice for publicly funded R&D
In the media 9 Sep 2026 Des acteurs pharmaceutiques à but non lucratif s’allient pour faire face à la baisse des financements Swissinfo
Scientific articles 15 Aug 2026 Identification of new Trypanosoma cruzi-specific protein synthesis inhibitors by using a developed high-throughput in vitro translation assay International Journal for Parasitology: Drugs and Drug Resistance
Scientific articles 5 Aug 2026 ICH E21: from landmark guidance to specific action for maternal and child health
Scientific articles 3 Aug 2026 A Phase IIa, Proof-of-Concept, Placebo-Controlled, Randomised Trial to Investigate the Efficacy and Safety of Oxfendazole as a Macrofilaricidal Drug in Adults Harbouring Lymphatic Filarial Worms Infectious Diseases and Therapy
Press releases 23 Apr 2015 Ministry of Health and partners disclose recommendations to overcome barriers to access to diagnosis and treatment for Chagas Disease in Colombia
Press releases 16 Dec 2014 DNDi receives US$ 10 million from USAID to develop new drugs for neglected filaria patients
Press releases 9 Dec 2014 Bayer and DNDi sign first agreement to develop an innovative oral treatment for human river blindness
Press releases 1 Dec 2014 World AIDS Day 2014: DNDi welcomes new Medicines Patent Pool licensing agreement and joins PEPFAR, Global Fund, PHTI commitment to reduce HIV treatment gap for HIV-positive children
Press releases 25 Nov 2014 Patient access to miltefosine in developing countries not secure despite award of US FDA PRV sold for USD 125 million
Press releases 25 Nov 2014 Strategic collaboration for developing urgent innovative therapies for neglected diseases in Latin America
Press releases 4 Nov 2014 Artesunate-Mefloquine Fixed-Dose Combination (ASMQ FDC) Proves Safe and Efficacious to Treat Children in Africa with Malaria
Press releases 2 Nov 2014 DNDi Receives USD 60 Million to Fill Research and Development Gaps for Neglected Patients
Press releases 15 Oct 2014 Study Results Support WHO Recommendations for Safe and Effective Kala-azar Treatments in Bangladesh
Press releases 6 Oct 2014 Phase III Clinical Study in Ethiopia Launched to Test Two Treatments for HIV-Visceral Leishmaniasis Co-infected Patients
Press releases 1 Oct 2014 Results of Large-Scale Roll Out of Combination Treatment for Kala-Azar in Eastern Africa Points to Urgency to Treat Disease Victims as Outbreak Surges in South Sudan
Press releases 24 Sep 2014 Celgene Global Health and DNDi Expand Collaboration to Identify Innovative Therapies to Benefit Patients with Neglected Tropical Diseases
Press releases 10 Aug 2014 The Global Chagas Disease Coalition stages high-level event to encourage increased access to diagnosis and treatment of patients fighting Chagas disease
Press releases 3 Jun 2014 DNDi Welcomes Progress Made at WHA in R&D Financing and Coordination for Developing Country Health Needs
